Business Wire

ARCTIC-BLUE-BEVERAGES

Share
Arctic Blue Beverages Launches New Ultra-Premium Product in Collaboration With Sarpaneva Design and Enters Web3 Through NFTs

Arctic Blue Legacy Gin is the Company’s latest product to be launched on the market. The product is handcrafted in Finland, matured for 24 months in oak barrels. Arctic Blue Legacy combines Timo Sarpaneva’s world-known glass design with the internationally awarded professionalism of master distiller Asko Ryynänen. Arctic Blue Legacy has been internationally awarded with the highest recognitions at the International Wine and Spirit Competition 2021 and the San Francisco World Spirits Competition 2022.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220915005925/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Visualization of Arctic Blue Legacy and its wooden case. (Photo: Business Wire)

The unique design of the Legacy bottle is based on the E415 prototype work designed in 1976 for Iittala by the international force in Finnish design, Timo Sarpaneva (1926-2006). Legacy’s prestige wooden case seeks inspiration from Sarpaneva’s sculpture, Gateway to Dreams. Together with Sarpaneva Design and Infinity, his designs have been subtly adapted to new uses, giving birth to Arctic Blue Legacy’s appearance.

“We are very excited. This fantastic opportunity with an extraordinary product is very inspiring as we are carrying on Timo’s legacy,” says Aleksei Sarpaneva, son of Timo Sarpaneva and CEO of Sarpaneva Design.

Arctic Blue Legacy’s purchase rights will be distributed as NFTs. A non-fungible token is a record on a blockchain associated with a unique, nonreplicable digital or physical asset. Main functionalities of NFTs are proof of digital ownership and holder benefits. The product is stored in Arctic Blue Beverages professional care, until the holder of the NFT decides to exercise their purchase right or transfer the ownership over the Ethereum blockchain. Arctic Blue Legacy is a luxury product, and proof of digital ownership enables a seamless global secondary market facilitating trading or gifting of the NFT.

Arctic Blue Beverages enters the Web3 in collaboration with the Web3 digital agency Struggle C&C Ltd.

“As agency partner, we feel privileged being part of Arctic Blue Beverage’s Web3 transformation. This is a big moment as Arctic Blue Beverages is one of the first listed Nordic companies entering the NFT space. Today’s technology offers new standards for digital ownership and community building”, says Kasper Karimaa, CEO of Struggle C&C.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220915005925/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma26.11.2025 12:00:00 CET | Press release

If approved, sonrotoclax will become the first BCL2 inhibitor for R/R MCL in the U.S., addressing a high unmet need in an aggressive cancerSonrotoclax previously received Breakthrough Therapy Designation based on clinically meaningful, rapid responses in R/R MCLBeOne Medicines will present the data supporting the NDA and Priority Review for the first time at ASH 2025 BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to a New Drug Application (NDA) for sonrotoclax, a next-generation BCL2 inhibitor, for the treatment of adult patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL), following treatment with a Bruton’s tyrosine kinase (BTK) inhibitor. “Sonrotoclax is advancing with remarkable speed, from Breakthrough Therapy Designation to Priority Review, all within a short window,” said Lai Wang, Ph.D., Global Head of R&D at BeOne.

Modon Holding Announces a Strategic Investment in Wellington Lifestyle Partners, Expanding Its Global Portfolio in Luxury Lifestyle Destination Development26.11.2025 11:15:00 CET | Press release

Modon joins a consortium of investors to elevate Wellington International equestrian showgrounds and develop an ultra-luxury destination integrating residential, hospitality and sports assets in Wellington, Palm Beach County, FloridaStrengthens Modon’s global presence and enables knowledge exchange across large-scale mixed-use, hospitality and lifestyle developments Abu Dhabi-based Modon Holding P.S.C (“Modon”) today announced a strategic investment in Wellington Lifestyle Partners (“WLP”), joining a consortium of existing investors in the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251125937208/en/ Aerial shot of Wellington International (Photo: AETOSWire) Modon’s investment will support the long-term development of Wellington International equestrian showgrounds and deliver a landmark ultra-luxury real estate development featuring high-end residences, a boutique hotel, a commercial marketplace and a championshi

Epassi Announces Leadership Transition26.11.2025 11:00:00 CET | Press release

Nickyl Raithatha to join as Group CEOPekka Rantala to remain on Board as Non-Executive Chair Epassi Group, a European leader in digital employee benefits technology, today announced that Nickyl Raithatha will join as Chief Executive Officer. Nickyl will assume the role in 2026. Pekka Rantala, who has served as CEO since September 2019, will remain on the Board as Non-Executive Chair. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251126015983/en/ Pekka Rantala and Nickyl Raithatha Over the past six years, Epassi Group has evolved from a Nordic success story into one of Europe’s leading SaaS employee benefits and wellbeing platforms. The company has expanded both its geographic footprint as well as its product portfolio, driven by a powerful combination of strong organic growth and strategic acquisitions, with backing from TA Associates and Warburg Pincus. Today it has a presence in ten countries and a team of 1,000 people. W

Enerin raises €15 million Series A to industrialise modular high-temperature heat pumps for global industry26.11.2025 10:00:00 CET | Press release

Norway-based technology leader in industrial heat pumps, Enerin AS, has raised €15 million in an oversubscribed Series A led by Climentum Capital, The Footprint Firm, Johnson Controls and Move Energy. The investment marks Enerin’s transition from technology pioneer to serial production. Proceeds will expand commercial and manufacturing operations, and accelerate next-generation development. Johnson Controls’ participation provides strategic validation and global reach from one of the world’s leading providers of energy systems. Enerin, a technology leader in high-temperature heat pumps, has raised €15 million (NOK 180 million) in a Series A led by Climentum Capital, The Footprint Firm, Johnson Controls and Move Energy, with participation from PSV Hafnium and Momentum. “This investment marks our shift from pioneering to full industrialisation, bringing proven high-temperature technology from Norway to industries worldwide,” said Arne Høeg, Founder and CEO of Enerin. “Industrial companie

IQM to Invest Over €40 Million to Expand Finland Production Facility, Accelerate Innovation and Fuel Growth26.11.2025 09:49:00 CET | Press release

The new facility will produce advanced quantum chips for error corrected quantum computers, almost double the cleanroom space and system assembly line capacity to produce up to 30 quantum computers per year. The integrated quantum computer production line will be one of the world’s most advanced of its kind combining fabrication of quantum chips and system assembly. The expansion is expected to be completed by the first quarter of 2026. The expansion is part of IQM’s long-term commitment to scale its infrastructure and execute the ambitious technology roadmap aiming at 1M quantum computers by 2033. IQM Quantum Computers, a global leader in superconducting quantum computers, today announced over €40 million investment to expand its state-of-the-art production facility in Finland. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251126943986/en/ This strategic expansion will accelerate the development, fabrication and testing of

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye